◀ Back to IL10
ADCYAP1 — IL10
Text-mined interactions from Literome
Wang et al., Regul Pept 1999
:
Previous reports indicate that VIP and the structurally related peptide
PACAP ,
inhibit IL-2 and
IL-10 production in antigen stimulated T lymphocytes ... The antagonists based on the neurotensin-VIP hybrid molecule did not affect the inhibitory
effect of
VIP/PACAP on IL-2 and
IL-10 production, confirming that astrocytes and T lymphocytes express different receptors
Delgado et al., J Biol Chem 1999
:
We showed previously that VIP and
PACAP inhibit the production of macrophage derived tumor necrosis factor-alpha,
interleukin (IL)-6 , nitric oxide, and IL-12
Leceta et al., Ann N Y Acad Sci 2000
(Inflammation) :
VIP/PACAP inhibit the production of TNF alpha, IL-6, IL-12, and nitric oxide ( NO ), and
stimulate IL-10 in peritoneal macrophages and Raw 264.7 cells ...
VIP/PACAP inhibit iNOS expression through reduction in NFkB and IRF-1 binding, and
augment IL-10 by increasing CREB binding
Kim et al., J Neuroimmunol 2002
:
The inclusion of an anti-IL-10 antibody completely abrogated PACAP inhibition of lipopolysaccharide (LPS) induced CD40 expression, suggesting that
PACAP inhibition is at least in part
mediated by
IL-10
Ganea et al., Crit Rev Oral Biol Med 2002
(Shock, Septic) :
In activated macrophages, VIP and
PACAP inhibit the production of pro-inflammatory agents ( cytokines, chemokines, and nitric oxide ), and
stimulate the production of the anti-inflammatory cytokine
IL-10
Zhang et al., Curr Eye Res 2005
:
To examine pituitary adenylate cyclase activating polypeptide ( PACAP ) receptors ( PAC1, VPAC1, and VPAC2 ) mRNA and the
effect of
PACAP on interleukin-6 (IL-6),
interleukin-8 (IL-8), and monocyte chemotactic protein-1 (MCP-1) expression in human retinal pigment epithelial cell line ( ARPE-19 ) stimulated with interleukin-1beta (IL-1beta)
Mester et al., J Mol Neurosci 2011
:
PACAP receptors have been identified on the retinal pigment epithelial cells and
PACAP has been shown to
inhibit interleukin secretion from pigment epithelial cells
Temerozo et al., PloS one 2013
:
VIP and
PACAP up-regulated macrophage secretion of the ß-chemokines CCL3 and CCL5 and the cytokine
IL-10 , whose neutralization reversed the neuropeptide induced inhibition of HIV-1 replication
Martinez et al., J Immunol 1996
:
In this study, we investigated the
effects of VIP and of the structurally related neuropeptide
PACAP-38 on the expression of
IL-10 in murine lymphocyte cultures ... The fact that VIP,
PACAP-38 , and forskolin, all known cAMP inducers, also
inhibit IL-10 production, suggests the participation of cAMP in signal transduction
Ganea et al., Adv Neuroimmunol 1996
:
In contrast, the inhibitory
effect of VIP and
PACAP on
IL-10 production proceeds through a direct transcriptional event
Jiang et al., Ann N Y Acad Sci 1998
:
These results indicate that both subsets of peripheral T lymphocytes express VIP1 and VIP2, but not PVR1 receptors, and that the inhibitory
effect of
VIP/PACAP on IL-2 and
IL-10 production is mediated by both VIP1 and VIP2 receptors
Delgado et al., J Immunol 1999
:
Although
VIP/PACAP do not
induce IL-10 by themselves, they enhance IL-10 production in LPS stimulated macrophages